Home Pain / Anesthetics Anesthesia Drugs Market Size 2019 – Growing Demand Status of Top Manufacturers...

Anesthesia Drugs Market Size 2019 – Growing Demand Status of Top Manufacturers with Industry Share, Size, Projection, Consumption Forecast to 2024

129
0

Anesthesia

The “Anesthesia Drugs Market” report 2019 provides information for market players, stakeholders, investors, and business strategists to achieve a leading position the market. It maintains the record of Unusual growth strategies adopted by various companies are creating new standards for competition in the global Anesthesia Drugs market. Businesses around the world are aiming at increasing their profit margin and establishing a stronghold in the global market. The impact of prevailing regulatory scenario on both regional and worldwide Anesthesia Drugs market is provided in detail in the report.

Get a Sample Copy of the Report – https://www.industryresearch.co/enquiry/request-sample/13999706  

Anesthesia Drugs Market Covers Key Players:

  • Baxter
  • Hospira
  • Abbott Laboratories
  • AstraZeneca
  • F. Hoffmann
  • La Roche AG
  • B. Braun Melsungen AG
  • AbbVie Inc.
  • Boehringer Ingelheim International GmbH
  • Eisai Co. Ltd
  • Fresenius SE & Co. KGaA

    Market Overview:

  • The anesthesia drugs market was valued at USD 4,512.11 million in 2018, and is estimated to be valued at USD 5,314.66 million in 2024, while witnessing a CAGR of 4.20% over the forecast period of 2019-2024. The key factors propelling the growth of this market are the increasing number of surgeries and new approvals of anesthetic drugs.
  • There are wide ranges of surgeries based on the length of stay for surgeries. These include elective surgery and emergency surgery. Based on procedures, there are wide ranges of surgeries, where open surgery is most common. Others include keyhole surgery, laparoscopic surgery, microsurgery, and cosmetic surgery. In recent years, several articles have reported a significant rise in the number of day care procedures (ambulatory surgery), and diagnostic and therapeutic services. This is primarily due to the increased dependence on advances made in anesthesia, surgical, and medical technologies.
  • Furthermore, the rise in surgeries is attributed to the increasing risk of various accidents, sports injuries, and diseases, globally. According to the Center of Disease Control and Prevention (CDC), more than 51 million inpatient surgeries and 53 million outpatient surgeries were performed in the United States in 2017. In the European region, in England, nearly 4.7 million patients were admitted for surgeries in 2014, as per the Royal College of Surgeons. This indicates the rising number of surgeries, which ultimately results into the rising demand for the anesthesia drugs and propels the growth of the anesthesia drugs market.

    Report Highlights:

    • The report provides a detailed analysis on current and future market trends to identify the investment opportunities
    • Market forecasts till 2024, using estimated market values as the base numbers
    • Key market trends across the business segments, Regions and Countries
    • Key developments and strategies observed in the market
    • Market Dynamics such as Drivers, Restraints, Opportunities and other trends
    • In-depth company profiles of key players and upcoming prominent players
    • Growth prospects among the emerging nations through 2024
    • Anesthesia Drugs Market opportunities and recommendations for new investments

    For More Information or Query or Customization Before Buying, Visit athttps://www.industryresearch.co/enquiry/pre-order-enquiry/13999706

    Scope of the Report:

  • Anesthesia is a drug that causes a reversible loss of sensation. There are several types of anesthetic drugs available in the market, such as general anesthesia, spinal anesthesia, IV regional anesthesia, local anesthesia, peripheral nerve block, and saddle block or caudal anesthesia.

    Key Market Trends:

    Propofol Sub-segment is Expected to Show the Fastest Growth in the General Anesthesia Drugs Segment

    The propofol sub-segment of the anesthesia drugs market is expected to experience a fast growth rate while witnessing a CAGR of 4.20% over the forecast period.

    Propofol is a drug that has been used for a long time for various surgical procedures requiring anesthesia. Teva Pharmaceuticals had stopped manufacturing propofol for a particular time; however, the drug returned to the market in 2013. Hospira is another major player in the propofol sub-segment. In 2015, Pfizer acquired Hospira and created a leading global established pharmaceutical (GEP) business. Some of the companies who manufacture propofol injections are Neon Laboratories Limited, Bharat Serums and Vaccines Limited, and Fresenius Kabi. The drug is always in demand in the market for utilization in different surgeries, and is expected to witness rapid growth in the coming years.

    North America Dominates the Market and is Expected to Follow the Same Trend Over the Forecast Period

    North America currently dominates the anesthesia drugs market and is expected to continue its stronghold for a few more years. The US anesthesia market is the largest regional market in the world. This market is driven by factors, such as the increasing number of surgeries, rising aging population with increasing chronic conditions, and advancements in anesthesia technologies.

    Purchase this Report (Price 4250 USD for single user license) – https://www.industryresearch.co/purchase/13999706

    Detailed TOC of Anesthesia Drugs Market Report 2019-2024:

    1 INTRODUCTION
    1.1 Study Deliverables
    1.2 Study Assumptions
    1.3 Scope of the Study

    2 RESEARCH METHODOLOGY

    3 EXECUTIVE SUMMARY

    4 MARKET DYNAMICS
    4.1 Market Overview
    4.2 Market Drivers
    4.2.1 Increasing Number of Surgeries
    4.2.2 New Approvals of Anesthetic Drugs
    4.2.3 Reduction in the Cost of Newly Invented Drugs
    4.3 Market Restraints
    4.3.1 Side Effects of General Anesthetics
    4.3.2 Lack of Skilled-Anesthetics
    4.3.3 Regulatory Issues
    4.4 Porter’s Five Forces Analysis
    4.4.1 Threat of New Entrants
    4.4.2 Bargaining Power of Buyers/Consumers
    4.4.3 Bargaining Power of Suppliers
    4.4.4 Threat of Substitute Products
    4.4.5 Intensity of Competitive Rivalry

    5 MARKET SEGMENTATION
    5.1 By Drug Type
    5.1.1 General Anesthesia Drugs
    5.1.1.1 Propofol
    5.1.1.2 Sevoflurane
    5.1.1.3 Desflurane
    5.1.1.4 Dexmedetomidine
    5.1.1.5 Remifentanil
    5.1.1.6 Midazolam
    5.1.1.7 Other General Anesthesia Drugs
    5.1.2 Local Anesthesia Drugs
    5.1.2.1 Bupivacaine
    5.1.2.2 Ropivacaine
    5.1.2.3 Lidocaine
    5.1.2.4 Chloroprocaine
    5.1.2.5 Articaine
    5.1.2.6 Benzocaine
    5.1.2.7 Local Anesthesia Drugs
    5.2 By Route of Administration
    5.2.1 Inhalation
    5.2.2 Injection
    5.2.3 Other Routes of Administration
    5.3 By Application
    5.3.1 General Surgeries
    5.3.2 Plastic Surgery
    5.3.3 Cosmetic Surgeries
    5.3.4 Dental Surgeries
    5.3.5 Other Applications
    5.4 Geography
    5.4.1 North America
    5.4.1.1 US
    5.4.1.2 Canada
    5.4.1.3 Mexico
    5.4.2 Europe
    5.4.2.1 Germany
    5.4.2.2 UK
    5.4.2.3 France
    5.4.2.4 Italy
    5.4.2.5 Spain
    5.4.2.6 Rest of Europe
    5.4.3 Asia-Pacific
    5.4.3.1 China
    5.4.3.2 Japan
    5.4.3.3 India
    5.4.3.4 Australia
    5.4.3.5 South Korea
    5.4.3.6 Rest of Asia-Pacific
    5.4.4 Middle East & Africa
    5.4.4.1 GCC
    5.4.4.2 South Africa
    5.4.4.3 Rest of Middle East & Africa
    5.4.5 South America
    5.4.5.1 Brazil
    5.4.5.2 Argentina
    5.4.5.3 Rest of South America

    6 COMPETITIVE LANDSCAPE
    6.1 Company Profiles
    6.1.1 Baxter
    6.1.2 Hospira
    6.1.3 Abbott Laboratories
    6.1.4 AstraZeneca
    6.1.5 F. Hoffmann-La Roche AG
    6.1.6 B. Braun Melsungen AG
    6.1.7 AbbVie Inc.
    6.1.8 Boehringer Ingelheim International GmbH
    6.1.9 Eisai Co. Ltd
    6.1.10 Fresenius SE & Co. KGaA

    7 MARKET OPPORTUNITIES AND FUTURE TRENDS

     

    Contact Us:

    Name: Ajay More

    Phone: US +14242530807/ UK +44 20 3239 8187

    Email: [email protected]

    Our Other Reports:

    Sevoflurane (Sevoflurane Source) Market Size, share 2019 – Globally Industry Demand, Emerging Trends, Regional Overview, Top Manufacture, Top Company Analysis, Business Strategy and Forecast to 2024

    Recycled Metals Market 2019 Globally Industry Demand, Trends, Regional Overview, Top Manufacture, Leading Company Analysis, Business Growth and Forecast to 2024: Industry Research Biz

    Global Next-Generation Sequencing (NGS) Market Size 2019 – Industry Share and Revenue Analysis by Types, Applications, Business Expansion Plans and Forecast to 2026

    Glue Stick Market 2019 – Global Industry Scope, Competition Strategies, Gross Margin Analysis by Size & Share, and Forecast to 2023

  • This site uses Akismet to reduce spam. Learn how your comment data is processed.